Paclitaxel, Ifosfamide, and Cisplatin Efficacy for First-Line Treatment of Patients With Intermediate- or Poor-Risk Germ Cell Tumors

PURPOSE: Paclitaxel, ifosfamide, and cisplatin (TIP) achieved complete responses (CRs) in two thirds of patients with advanced germ cell tumors (GCTs) who relapsed after first-line chemotherapy with cisplatin and etoposide with or without bleomycin. We tested the efficacy of first-line TIP in patien...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Oncol
Autors principals: Feldman, Darren R., Hu, James, Dorff, Tanya B., Lim, Kristina, Patil, Sujata, Woo, Kaitlin M., Carousso, Maryann, Hughes, Amanda, Sheinfeld, Joel, Bains, Manjit, Daneshmand, Siamak, Ketchens, Charlene, Bajorin, Dean F., Bosl, George J., Quinn, David I., Motzer, Robert J.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2016
Matèries:
ORIGINAL REPORTS
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5320896/
https://ncbi.nlm.nih.gov/pubmed/27185842
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.66.7899
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars